Use of the radiation therapy oncology group recursive partitioning analysis classification system and predictors of survival in 19 women with brain metastases from ovarian carcinoma

Cancer

Volumn 104, Issue 10, 2005, Pages 2174-2180

  Chen, Philip G ^a   Lee, Shili Yuan ^a   Barnett, Gene H ^a   Vogelbaum, Michael A ^a   Saxton, Jerrold P ^a   Fleming, Peter A ^a   Suh, John H ^a,b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b Department of Radiation Oncology ^*  (United States)

Author keywords

Brain metastases; Ovarian carcinoma; RPA class

Indexed keywords

ADULT; AGED; ANALYTIC METHOD; BRAIN METASTASIS; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; HUMAN; OVARY CARCINOMA; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RECURSIVE PARTITIONING ANALYSIS; RETROSPECTIVE STUDY; REVIEW;

ADULT; AGED; BRAIN NEOPLASMS; CARCINOMA; FEMALE; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 27644448816     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.21472     Document Type: Review

References (27)

1. Barker GH, Orledge J, Wiltshaw E. Involvement of the central nervous system in patients with ovarian carcinoma. Br J Obstet Gynaecol. 1981;88:690-694.
2. Budd GT, Webster KD, Reimer RR, et al. Treatment of advanced ovarian cancer with cisplatin, adriamycin and cyclophosphamide: effect of treatment and incidence of intracranial metastases. J Surg Oncol. 1983;24:192-195.
3. Hardy JR, Harvey VJ. Cerebral metastases in patients with ovarian cancer treated with chemotherapy. Gynecol Oncol. 1989;33:296-300.
4. Bruzzone M, Campora E, Chiara S, et al. Cerebral metastases secondary to ovarian cancer: still an unusual event. Gynecol Oncol. 1993;49:37-40.
5. Mayer RJ, Berkowitz RS, Griffiths CT. Central nervous system involvement by ovarian carcinoma: a complication of prolonged survival with metastatic disease. Cancer. 1978;41:776-783.
6. Larson DM, Copeland LJ, Moser RP, et al. Central nervous system metastases in epithelial ovarian cancer. Obstet Gynecol. 1986;68:746-750.
7. Cohen ZR, Suki D, Weinberg JS, et al. Brain metastases in patients with ovarian carcinoma: prognostic factors and outcome. J Neuro-oncol. 2004;66:313-325.
8. Kaminsky-Forrett MC, Weber B, Conroy T, et al. Brain metastases from epithelial ovarian carcinoma. Int J Gynecol Cancer. 2000;10:366-371.
9. Borgelt B, Gelber R, Kramer S, et al. The palliation of brain metastases: final results of the first two studies by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys. 1980;6:1-9.
10. Lagerwaard FJ, Levendag PC, Nowak PJ, et al. Identification of prognostic factors in patients with brain metastases: a review of 1292 patients. Int J Radiat Oncol Biol Phys. 1999;43:795-803.
11. Posner JB, Chernik NL. Intracranial metastases from systemic cancer. Adv Neurol. 1978;19:579-592.
12. Caspar L, Scott C, Rotman M, et al. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys. 1997;37:745-751.
13. Gaspar LE, Scott C, Murray K, Curran W. Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases. Int J Radiat Oncol Biol Phys. 2000;47:1001-1006.
14. McMeekin DS, Kamelle SA, Vasilev SA, et al. Ovarian cancer metastatic to the brain: What is the optimal management? J Surg Oncol. 2001;78:194-200; discussion 200-201.
15. Corn BW, Mehta MP, Buatti JM, et al. Stereotactic irradiation: potential new treatment method for brain metastases resulting from ovarian cancer. Am J Clin Oncol. 1999;22:143-146.
16. Cormio G, Maneo A, Colamaria A, et al. Surgical resection of solitary brain metastasis from ovarian carcinoma: an analysis of 22 cases. Gynecol Oncol. 2003;89:116-119.
17. Anupol N, Ghamande S, Odunsi K, et al. Evaluation of prognostic factors and treatment modalities in ovarian cancer patients with brain metastases. Gynecol Oncol. 2002;85:487-492.
18. LeRoux PD, Berger MS, Elliott JP, Tamimi HK. Cerebral metastases from ovarian carcinoma. Cancer. 1991;67:2194-2199.
19. Geisler JP, Geisler HE. Brain metastases in epithelial ovarian carcinoma. Gynecol Oncol. 1995;57:246-249.
20. Pothuri B, Chi DS, Reid T, et al. Craniotomy for central nervous system metastases in epithelial ovarian carcinoma. Gynecol Oncol. 2002;87:133-137.
21. Bindal AK, Bindal RK, Hess KR, et al. Surgery versus radiosurgery in the treatment of brain metastasis. J Neurosurg. 1996;84:748-754.
22. Auchter RM, Lamond JP, Alexander E, et al. A multi-institutional outcome and prognostic factor analysis of radiosurgery for resectable single brain metastasis. Int J Radiat Oncol Biol Phys. 1996;35:27-35.
23. Muacevic A, Kreth FW, Horstmann GA, et al. Surgery and radiotherapy compared to gamma knife radiosurgery in the treatment of solitary cerebral metastases of small diameter. J Neurosurg. 1999;91:35-43.
24. Nieder C, Nestle U, Motaref B, et al. Prognostic factors in brain metastases: should patients be selected for aggressive treatment according to recursive partitioning analysis (RPA) classes? Int J Radiat Oncol Biol Phys. 2000;46:297-302.
25. Corn BW, Greven KM, Randall ME, et al. The efficacy of cranial irradiation in ovarian cancer metastatic to the brain: analysis of 32 cases. Obstet Gynecol. 1995;86:955-959.
26. Kolomainen DF, Larkin JM, Badran M, et al. Epithelial ovarian cancer metastasizing to the brain: a late manifestation of the disease with an increasing incidence. J Clin Oncol. 2002;20:982-986.
27. Sanderson A, Bonington SC, Carrington BM, et al. Cerebral metastasis and other cerebral events in women with ovarian cancer. Clin Radiol. 2002;57:815-819.